MedTrace Logo

Human Faecal Microbiota in Type 2 Diabetes

NCT02694172 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2016-02-29

No results posted yet for this study

Summary

The main objective of the clinical trial is to investigate whether overweight type 2 diabetic patients have a different fecal microbiota profile compared with age, gender, BMI matched subjects and with lean healthy subjects before and after the consumption of fiber rich cereal bars.

Conditions

Interventions

OTHER

Fiber rich cereal bars

Two cereals per day and per subject for 4 weeks

Sponsors & Collaborators

  • University Hospital, Geneva

    collaborator OTHER

  • Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

    collaborator OTHER

  • Imperial College London

    collaborator OTHER

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Alain Golay, Prof · University Hospital, Geneva

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2009-06-30
Completion
2011-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02694172 on ClinicalTrials.gov